Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.

Herrera-Restrepo O, Jutlla G, Graham J, Carrico J, Grace M, Kocaata Z, Clements DE, Burman C, Andani A, Shah H

Open source

DOI
10.1007/s40273-026-01599-z
Published
2026 Jun
Container
PharmacoEconomics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40273-026-01599-z,
  title = {Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.},
  author = {Herrera-Restrepo O and Jutlla G and Graham J and Carrico J and Grace M and Kocaata Z and Clements DE and Burman C and Andani A and Shah H},
  year = {2026},
  journal = {PharmacoEconomics},
  doi = {10.1007/s40273-026-01599-z},
  url = {https://doi.org/10.1007/s40273-026-01599-z}
}

RIS

TY  - JOUR
TI  - Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.
AU  - Herrera-Restrepo O
AU  - Jutlla G
AU  - Graham J
AU  - Carrico J
AU  - Grace M
AU  - Kocaata Z
AU  - Clements DE
AU  - Burman C
AU  - Andani A
AU  - Shah H
PY  - 2026
JO  - PharmacoEconomics
DO  - 10.1007/s40273-026-01599-z
UR  - https://doi.org/10.1007/s40273-026-01599-z
ER  - 

APA

O, H., G, J., J, G., J, C., M, G., Z, K., DE, C., C, B., A, A., & H, S. (2026). Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01599-z

Source records